Literature DB >> 16003837

Osteonecrosis of the jaw and bisphosphonates.

Sook-Bin Woo, Karen Hande, Paul G Richardson.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2005        PMID： 16003837

Source DB:  PubMed          Journal:  N Engl J Med        ISSN： 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  10 in total

1.  Osteonecrosis of maxilla secondary to bisphosphonate therapy: a case report.

Authors:  Trupti Kolur; Sanjiv C Nair; Balasubramanya Kumar
Journal:  J Maxillofac Oral Surg       Date:  2011-12-21

Review 2.  Skeletal complications of breast cancer therapies.

Authors:  Angela Hirbe; Elizabeth A Morgan; Ozge Uluçkan; Katherine Weilbaecher
Journal:  Clin Cancer Res       Date:  2006-10-15       Impact factor: 12.531

3.  Higher incidence of Osteonecrosis of the Jaw (ONJ) in patients with metastatic castration resistant prostate cancer treated with anti-angiogenic agents.

Authors:  Jeanny B Aragon-Ching; Yang-Min Ning; Clara C Chen; Lea Latham; Jean-Pierre Guadagnini; James L Gulley; Philip M Arlen; John J Wright; Howard Parnes; William D Figg; William L Dahut
Journal:  Cancer Invest       Date:  2009-02       Impact factor: 2.176

4.  Experimental development of bisphosphonate-related osteonecrosis of the jaws in rodents.

Authors:  Nicolau Conte Neto; Luis C Spolidorio; Cleverton R Andrade; Alliny S Bastos; Morgana Guimarães; Elcio Marcantonio
Journal:  Int J Exp Pathol       Date:  2013-02       Impact factor: 1.925

Review 5.  Phosphate: known and potential roles during development and regeneration of teeth and supporting structures.

Authors:  Brian L Foster; Kevin A Tompkins; R Bruce Rutherford; Hai Zhang; Emily Y Chu; Hanson Fong; Martha J Somerman
Journal:  Birth Defects Res C Embryo Today       Date:  2008-12

6.  Inhibition of bone resorption by bisphosphonates interferes with orthodontically induced midpalatal suture expansion in mice.

Authors:  Till Koehne; Bärbel Kahl-Nieke; Michael Amling; Heike Korbmacher-Steiner
Journal:  Clin Oral Investig       Date:  2018-01-18       Impact factor: 3.573

Review 7.  Tolerability of different dosing regimens of bisphosphonates for the treatment of osteoporosis and malignant bone disease.

Authors:  Raja S Bobba; Karen Beattie; Bill Parkinson; Dinesh Kumbhare; Jonathan D Adachi
Journal:  Drug Saf       Date:  2006       Impact factor: 5.228

8.  Closure of an open wound associated with bisphosphonate-related osteonecrosis of the jaw in a breast cancer patient.

Authors:  Nafiseh Soolari; Ahmad Soolari
Journal:  Open Dent J       Date:  2011-10-21

Review 9.  Bisphosphonate-associated osteonecrosis of the jaw: the rheumatologist's role.

Authors:  Franco Capsoni; Matteo Longhi; Roberto Weinstein
Journal:  Arthritis Res Ther       Date:  2006       Impact factor: 5.156

10.  Dendritic Cells Cause Bone Lesions in a New Mouse Model of Histiocytosis.

Authors:  Frédéric Grosjean; Sonia Nasi; Pascal Schneider; Véronique Chobaz; Alexandra Liu; Vanessa Mordasini; Kristell Moullec; Paolo Vezzoni; Christine Lavanchy; Nathalie Busso; Hans Acha-Orbea; Driss Ehirchiou
Journal:  PLoS One       Date:  2015-08-06       Impact factor: 3.240
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.